Literature DB >> 12809794

Dopaminergic excitation of the goat carotid body is mediated by the serotonin type 3 receptor subtype.

Jay K Herman1, Ken D O'Halloran, Patrick L Janssen, Gerald E Bisgard.   

Abstract

The purpose of the present study was to use chemoafferent recordings from the goat carotid body (CB) to pharmacologically identify the putative low affinity excitatory receptor for dopamine (DA). Close arterial injections of DA (1-50 microg kg(-1)) induced a dose-dependent excitatory burst followed by inhibition of the CB chemoafferent activity. The inhibition is likely DA D(2) receptor-mediated as it was blocked by domperidone (0.5-1.0 mg kg(-1) iv). The initial high frequency burst of CB chemoafferent activity could not be attenuated by selective antagonists for the DA D(1-4) receptors but could be blocked by D-tubocurarine or the selective serotonin(3) (5-HT(3)) receptor antagonists, tropisetron and MDL72222. The selective nicotinic antagonists, hexamethonium and vecuronium, were without effect. Selective blockade of the 5-HT(3)-receptor subtype using tropisetron significantly reduced both normoxic and hypoxic unitary CB discharge. These results suggest that DA-mediated excitation of the goat CB chemosensitive afferents occurs via the 5-HT(3)-receptor subtype and that the 5-HT(3)-receptor may exert an excitatory modulation of CB output during normal physiological responses in the goat.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12809794     DOI: 10.1016/s1569-9048(03)00088-0

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  2 in total

1.  Short-term hypoxia increases tyrosine hydroxylase immunoreactivity in rat carotid body.

Authors:  Kouki Kato; Misuzu Yamaguchi-Yamada; Yoshio Yamamoto
Journal:  J Histochem Cytochem       Date:  2010-06-07       Impact factor: 2.479

Review 2.  Carotid body modulation in systolic heart failure from the clinical perspective.

Authors:  Piotr Niewinski
Journal:  J Physiol       Date:  2016-04-13       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.